Haemonetics Issues $500M Convertible Senior Notes Offering

Choate represented Haemonetics in connection with the issuance of $500M of 0.00% convertible senior notes due 2026 via a private offering pursuant to Rule 144A of the Securities Act of 1933, as amended. In connection with the offering, Haemonetics purchased “capped calls” to reduce the dilution upon conversion of the notes. Haemonetics is a global healthcare company that provides a suite of innovative hematology products and solutions.